Next-Generation KIT Inhibitor Shows Promise in Systemic Mastocytosis

(MedPage Today) -- Emerging data presented at the American Academy of Allergy, Asthma & Immunology (AAAAI) annual meeting highlighted the continued progress in targeted therapies for systemic mastocytosis, including next-generation approaches...
Source
MedPage Today
Opens original article in a new tab



